Minaris Advanced Therapies is a global CDMO and testing organization dedicated to advancing cell and gene therapies from development through commercial supply. With decades of experience, over 7,500 GMP batch releases, and commercial-ready facilities spanning three continents, we bring unmatched scale and expertise to our partners.